PhysioSonics, a US-based medical device company making ultrasound imaging technology to monitor blood flow in the brain, has reportedly raised less than $10m in a series B round led by New York-listed Medtronic.
News provider Xconomy said angel investor Kirby Cramer was also part of the B round alongside Medtronic.
In an interview with Xconomy, Brad Harlow, chief executive of PhysioSonics, said his company had raised less than the $8m he raised in the series A round.
Medtronic, which confirmed its investment by email, and medical device peer Johnson & Johnson have both now invested in PhysioSonics, Harlow said.